Zhejiang Cancer Hospital

Zhejiang Cancer Hospital is a government-run specialist hospital in Hangzhou, Zhejiang Province, serving cancer patients from Zhejiang and surrounding regions. Established in 1963, it was among the earliest dedicated cancer hospitals founded in China and has developed as both a clinical treatment center and a base for oncology research. Its work covers the diagnosis, treatment, and ongoing care of patients with cancer, supported by medical specialists, clinical departments, and research activities focused on cancer prevention, diagnosis, therapy, and outcomes. The hospital is also associated with the Zhejiang Cancer Research Institute. The institute brings together cancer clinicians and biomedical researchers whose work is directed toward understanding cancer and developing improved approaches to treatment. This combination of hospital care and research gives the institution a role beyond routine medical provision: it functions as part of Zhejiang’s regional oncology infrastructure and contributes to the training, investigation, and application of cancer medicine. On May 9, 2019, Zhejiang Cancer Hospital became the affiliated Cancer Hospital of the University of Chinese Academy of Sciences. It also became the hosting hospital of the Institute of Cancer Research and Basic Medical Science of the Chinese Academy of Medical Sciences. These affiliations linked the hospital more closely with major Chinese academic and research networks and formalized its position as a platform for clinical oncology and cancer science. The hospital’s primary service area is Zhejiang Province, although its specialist status allows it to receive patients from nearby areas. Publicly available reference material does not provide a complete current breakdown of departments, bed capacity, annual patient volumes, financial information, or executive leadership. Accordingly, this profile focuses on the institution’s documented history, public role, affiliations, and broad clinical and research functions rather than asserting unverified operational details.

Zhejiang Cancer Hospital was established in 1963 in Hangzhou, Zhejiang Province. Its creation placed it among the earliest dedicated cancer hospitals in China, reflecting the development of specialist oncology institutions within the country’s public medical system. From its beginning, the hospital’s purpose was centered on cancer care rather than general medicine, giving it a specialized regional role in the diagnosis and treatment of malignant disease. Over time, the institution developed beyond a treatment facility. It houses the Zhejiang Cancer Research Institute, where cancer clinicians and scientists conduct research related to the causes, detection, management, and possible cures of cancer. The coexistence of clinical services and research enables the hospital to connect medical practice with scientific investigation, although the publicly available reference material does not specify the full range of laboratories, research programs, or clinical departments currently operating there. The hospital provides services to patients from Zhejiang Province and nearby regions. Its specialist focus makes it part of the referral network for patients requiring oncology expertise. The available sources describe it as a government-run cancer hospital, but they do not provide sufficient information to characterize its administrative structure in more detail or to identify a separate corporate parent, private owner, or listed entity. A significant institutional development occurred on May 9, 2019. Zhejiang Cancer Hospital became the affiliated Cancer Hospital of the University of Chinese Academy of Sciences. At the same time, it became the hosting hospital of the Institute of Cancer Research and Basic Medical Science of the Chinese Academy of Medical Sciences. These arrangements strengthened its connections with higher education and national-level medical research and reinforced its dual identity as a cancer-care provider and research institution. The hospital therefore occupies a regional and academic position within Chinese oncology: it offers specialist care to cancer patients, supports research through the Zhejiang Cancer Research Institute, and participates in broader university and academy-linked medical work. Public reference material does not establish additional dated expansions, leadership changes, financial results, product-style offerings, or major controversies, so those areas remain unpopulated rather than inferred.

• 2019

  Academic and research affiliations formalized

  [1]Zhejiang Cancer Hospitalen.wikipedia.org

  On May 9, 2019, the hospital became the affiliated Cancer Hospital of the University of Chinese Academy of Sciences and the hosting hospital of the Institute of Cancer Research and Basic Medical Science of the Chinese Academy of Medical Sciences.

• 1963

  Hospital established

  [1]Zhejiang Cancer Hospitalen.wikipedia.org

  Zhejiang Cancer Hospital was established in Hangzhou as one of the earliest dedicated cancer hospitals in China.

A public, specialist oncology institution combining cancer treatment with clinical and biomedical research, with a regional service role in Zhejiang and academic affiliations within China’s national research system.

• Medical services

  Oncology diagnosis and treatment

  The hospital provides specialist medical services for cancer patients, including the evaluation and management of malignant disease. Public reference material identifies cancer treatment as its central clinical function but does not provide a verified current list of individual treatment modalities or departments.

• Medical research

  Cancer research

  The Zhejiang Cancer Research Institute operates within the hospital and brings together cancer clinicians and scientists. Its documented purpose is to investigate cancer and seek improved methods for curing or treating the disease, linking research activity with the hospital’s clinical mission.

• 2019

  Academic affiliation and research-hosting arrangementStrategy

  Background

  The hospital’s specialist clinical role was linked with national academic and medical research institutions.

  Action taken

  On May 9, 2019, Zhejiang Cancer Hospital became the affiliated Cancer Hospital of the University of Chinese Academy of Sciences and the hosting hospital of the Institute of Cancer Research and Basic Medical Science of the Chinese Academy of Medical Sciences.

  Aftermath

  The arrangement strengthened the hospital’s documented connection to university education and Chinese Academy of Medical Sciences research. Specific operational or financial effects are not stated in the available reference material.

  Source

1. 1Zhejiang Cancer Hospitalen.wikipedia.org
2. 2Zhejiang Cancer Hospital official websitezchospital.com
3. 3Zhejiang Cancer Hospital listingzjcc.org.cn
4. 4Zhejiang Cancer Hospital publications indexed by PubMedpubmed.ncbi.nlm.nih.gov
5. 5Zhejiang Cancer Hospitalwikidata.org